Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

HHS Regulatory Agenda Omits Drug Pricing Actions – Unless OTC Switches Still Count

Dec 22 2017

• By Michael McCaughan

Money Wave

Related Content

340B Penny Pricing, Civil Monetary Penalty Revisions On Deck In Proposed Rule

Dec 15 2017

US FDA's Regulatory Pipeline Includes DTC, Inspection Requirement Updates

Dec 21 2017

Medicaid Add-On Rebates For Line Extensions Remain A Judgment Call

Feb 11 2016

NSURE In Play If Not Yet In FDA’s Regulatory Playbook

Jul 13 2015

Additional Topics

United States Pricing Debate Prescription To OTC Switch Government Payers Reimbursement Market Access Medicaid Policy BioPharmaceutical

More from Pricing Debate

More from Market Access

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window